ASHPOfficial

The podcast provides information relevant to the use of direct oral anticoagulants as the therapy relates to hospital discharge, maintenance therapy in the community setting, and managing patient access to mitigate gaps in therapy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Kelly Brunk and Daniel Cobaugh will discuss Kelly’s journey from a career as a professional dancer followed by a promising pharmacy career. They will hit upon Kelly’s’ career and life experiences, and his guidance for other LGBTQ pharmacy technicians, student pharmacists, pharmacy residents, and pharmacists.

In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, ASHP's Daniel Cobaugh speaks with Jorge Garcia and Leyner Martinez, discussing their unique experiences as a couple who are leaders in health-system pharmacy practice. They will hit upon their early career experiences, navigating residency as a couple, balancing the demands of family and career, and their advice for LGBTQ people in pharmacy. 

In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Mr. David Chen, Dr. Lindsey Amerine, and Dr. William Kernan discuss the AJHP Practice Research Report "Pharmacy executive and mid-level manager perceptions of leadership in contemporary health-system pharmacy” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The first in a five-part series, this episode of Tools of The Trade discusses the importance of data literacy, practical pharmacy examples, and common data sources to get started in data analytics. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Emily Laswell and Dr. McKenzie Grinalds discuss the AJHP Therapy Update, “Rapid administration of antiseizure medications: Review of safety, effectiveness, and implications for pharmacy practice” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores the evolving landscape of GLP-1 therapies, highlighting new formulations, emerging clinical uses and future directions of metabolic care. The episode reviews access and affordability while also providing a clear understanding of where GLP-1 therapy is headed in this rapidly changing field.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

The use of biotherapies has surged in recent years, creating new challenges and opportunities for pharmacy. In this episode, three experienced pharmacists in the world of biotherapeutic drugs will review key considerations for working with these agents. Their discussion will cover biosafety review processes and how to develop the structure to support ongoing management of biotherapeutics.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast describes a research project at an academic health system to pilot an outpatient pharmacy continuous glucose monitoring service. Listeners will learn about the process of developing and implementing a continuous glucose monitoring service within an outpatient pharmacy setting. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the urgency for pharmacists to transition from using Cockcroft-Gault eCrCL to non-race based estimated glomerular filtration rate (eGFR) to improve medication-related decision-making in persons with reduced kidney function.  Listeners will learn how to transition from C-G eCrCL to eGFR adjusted for body surface area to improve medication effectiveness and safety in persons with chronic kidney disease.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.